Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ohno

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 26, 2008
A contact investigation of the transmission of Mycobacterium tuberculosis from a nurse working in a newborn nursery and maternity wardHitoshi Ohno, Yumiko Ikegami, Kenji Kishida, et al.
Hematological Oncology|January 20, 2020
Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistryHitoshi Ohno, Miho Nakagawa, Chiyuki Kishimori, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 30, 2023
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot<sup>®</sup> ) evaluated by global coagulation assay in patients with acquired haemophilia AMasahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, et al.
Leukemia & Lymphoma|April 12, 2024
Two recurrent types of <i>IGH</i>::5' <i>BCL2</i> breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the <i>VDJ</i> and class switch recombination processes, respectivelyFumiyo Maekawa, Masahiko Hayashida, Kayo Takeoka, et al.
Blood|March 12, 2013
BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangementsZhengfei Lu, Albert G Tsai, Takashi Akasaka, et al.
International Journal of Hematology|September 2, 2019
Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 studyTakeshi Takahashi, Kensuke Usuki, Kosei Matsue, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|May 17, 2021
Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2<sup>V617F</sup>-myeloproliferative neoplasmKatsuhiro Fukutsuka, Futoshi Iioka, Fumiyo Maekawa, et al.
The Tohoku Journal of Experimental Medicine|August 27, 2004
Successful allogeneic bone marrow transplantation for acute myelogenous leukemia after drug-induced cardiomyopathyMitsuru Itoh, Kazuya Iwai, Yasuko Kotone-Miyahara, et al.
Annals of Hematology|December 19, 2019
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocationKyosuke Yamaguchi, Yasushi Kubota, Chiyuki Kishimori, et al.
International Journal of Hematology|October 18, 2022
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemiaNaohiro Sekiguchi, Senji Kasahara, Toshihiro Miyamoto, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 26, 2008
A contact investigation of the transmission of Mycobacterium tuberculosis from a nurse working in a newborn nursery and maternity wardHitoshi Ohno, Yumiko Ikegami, Kenji Kishida, et al.
Hematological Oncology|January 20, 2020
Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistryHitoshi Ohno, Miho Nakagawa, Chiyuki Kishimori, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 30, 2023
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot<sup>®</sup> ) evaluated by global coagulation assay in patients with acquired haemophilia AMasahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, et al.
Leukemia & Lymphoma|April 12, 2024
Two recurrent types of <i>IGH</i>::5' <i>BCL2</i> breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the <i>VDJ</i> and class switch recombination processes, respectivelyFumiyo Maekawa, Masahiko Hayashida, Kayo Takeoka, et al.
Blood|March 12, 2013
BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangementsZhengfei Lu, Albert G Tsai, Takashi Akasaka, et al.
International Journal of Hematology|September 2, 2019
Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 studyTakeshi Takahashi, Kensuke Usuki, Kosei Matsue, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|May 17, 2021
Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2<sup>V617F</sup>-myeloproliferative neoplasmKatsuhiro Fukutsuka, Futoshi Iioka, Fumiyo Maekawa, et al.
The Tohoku Journal of Experimental Medicine|August 27, 2004
Successful allogeneic bone marrow transplantation for acute myelogenous leukemia after drug-induced cardiomyopathyMitsuru Itoh, Kazuya Iwai, Yasuko Kotone-Miyahara, et al.
Annals of Hematology|December 19, 2019
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocationKyosuke Yamaguchi, Yasushi Kubota, Chiyuki Kishimori, et al.
International Journal of Hematology|October 18, 2022
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemiaNaohiro Sekiguchi, Senji Kasahara, Toshihiro Miyamoto, et al.
Pageof 12